Clinical Trial

REspiratory diSEAse cohoRt Studies of CHinese Medicine for Asthma (RESEARCH- Asthma)

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 18, 2024 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to define the standard use of TCM treatment regimen as the TCM cohort group and the non-TCM cohort group of those who use conventional Western medicine treatment without the standard TCM treatment regimen through a multi-center, large-sample prospective cohort study design. To evaluate the clinical efficacy and safety of TCM treatment regimens in the treatment of bronchial asthma, and to provide high-quality evidence for the promotion and application of TCM syndrome differentiation treatment in bronchial asthma.
Trial Details
NCT Number NCT06373692
Lead Sponsor Henan University of Traditional Chinese Medicine
Collaborators: The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Third Affiliated Hospital of Henan University of Traditional Chinese Medicine, Hebei Provincial Hospital of Traditional Chinese Medicine, Peking University People's Hospital, The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, The First Affiliated Hospital of Zhengzhou University, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Conditions Bronchial Asthma
Enrollment 1,508 participants
Start Date 2024-05-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2024-04-18